MODERN ASPECTS OF TREATMENT OF GENITAL HERPES INFECTION
Abstract
This article describes the present views on the treatment of genital herpes infection. Examined topical therapies HSV.
About the Authors
I. O. Makarov
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
T. V. Ovsyannikova
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
I. A. Kulikov
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Елисеева М.Ю., Мынбаев О.В. Вспомогательная иммунотерапия ВПЧ-ассоциированных поражений слизистых оболочек и кожи урогенитальной и перианальной локализации (Системный обзор литературы и метаанализ применения Инозин Пранобекса). Consilium medicum. 2009; 11 (5).
2. Молочков В.А., Семенова Т.Б., Киселев В.И. и соавт. Генитальные вирусные инфекции. М. 2009; 207 с.
3. Новиков Д.К. Клиническая иммунопатология. М. 2009; 680 с.
4. Прилепская В.Н., Роговская С.И. Возможности изопринозина в лечении хронических цервицитов и вагинитов. Рус. мед. журнал. 2008; 16 (1): 5-9.
5. Серов В.Н., Твердикова М.А., Вересова А.А. Иммуномодуляторы в комплексной терапии воспалительных заболеваний малого таза. РМЖ «Мать и дитя». 2011; 20: 1218-22.
6. Уварова Е.В., Кумыкова З.Х., Муслимова С.Ю. Терапевтические возможности применения химически чистого иммуномодулятора инозин пранобекса при вирусных заболеваниях у детей и подростков. Гинекология. 2011; 12 (6): 60-66.
7. Braunstein S.L., Ingabire C.M., Kestelyn E. Еt al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm. Deseases. 2011; 38 (5): 385-90.
8. Gardella C. Herpes simplex virus genital infections: current concepts. Curr. Infect. Dis. Rep. 2011; 13 (6): 588-94.
9. Meylan P. Herpes simplex virus infections, an update for the practitioner. Rev. Med. Suisse. 2011; 27 (2): 886-8.
10. Patel P., Bush T., Mayer K.H. et al. Prevalence and Risk Factors Associated With Herpes Simplex Virus-2 Infection in a Contemporary Cohort of HIV-Infected Persons in the United States. Sex Transm. Deseases. 2012; 39 (3): 154-60.
11. Stoner K.A., Reighard S.D., Vicetti Miguel R.D. et al. Recalcitrance of bacterial vaginosis among herpes-simplex-virustype2-seropositive women. J. Obstet. Gynaecol. Res. 2012; 38 (1): 77-83.
12. Thompson R.L., Sawtell N.M. The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections. J. Neurovirol. 2011; 17 (6): 552-8.
13. Viera M.H., Amini S., Huo R. et al. Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options. Int. J. Dermatol. 2010; 49 (7): 733-49.
14. Westhoff G.L., Little S.E., Caughey A.B.Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet. Gynecol. Surv. 2011; 66 (10): 629-38.
For citation:
Makarov I.O., Ovsyannikova T.V., Kulikov I.A. MODERN ASPECTS OF TREATMENT OF GENITAL HERPES INFECTION. Obstetrics, Gynecology and Reproduction. 2013;7(2):27-28. (In Russ.)
Views: 203
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
